| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Cell Biology, Faculty of Biology, Complutense University, Madrid, Spain
Rheumatoid arthritis is a chronic, systemic, autoimmune, and inflammatory disorder that affects the synovial lining of the joints. We describe the beneficial effects of the pituitary adenylate cyclase-activating polypeptide (PACAP) in the collagen-induced arthritis experimental murine model being proposed as a novel therapeutic approach in the treatment of rheumatoid arthritis. PACAP greatly decreases arthritis frequency and severity in the studied mice by improving clinical symptoms, ameliorating joint damage, and blocking both the inflammatory and autoimmune mediators which are the main keys of the pathogenesis of this disease. With this study, PACAP emerges as a promising candidate for the treatment of a pathology with a high world incidence but currently no effective treatment.
This article has been cited by other articles:
|
|
 |
|
  C. Sekine, T. Sugihara, S. Miyake, H. Hirai, M. Yoshida, N. Miyasaka, and H. Kohsaka Successful Treatment of Animal Models of Rheumatoid Arthritis with Small-Molecule Cyclin-Dependent Kinase Inhibitors J. Immunol., February 1, 2008; 180(3): 1954 - 1961. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Gonzalez-Rey, A. Chorny, F. O'Valle, and M. Delgado Adrenomedullin Protects from Experimental Arthritis by Down-Regulating Inflammation and Th1 Response and Inducing Regulatory T Cells Am. J. Pathol., January 1, 2007; 170(1): 263 - 271. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.P. GOMARIZ, Y. JUARRANZ, C. ABAD, A. ARRANZ, J. LECETA, and C. MARTINEZ VIP-PACAP System in Immunity: New Insights for Multitarget Therapy Ann. N.Y. Acad. Sci., July 1, 2006; 1070(1): 51 - 74. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Delgado, A. Chorny, E. Gonzalez-Rey, and D. Ganea Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo J. Leukoc. Biol., December 1, 2005; 78(6): 1327 - 1338. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Martinez, Y. Juarranz, C. Abad, A. Arranz, B. G. Miguel, F. Rosignoli, J. Leceta, and R. P. Gomariz Analysis of the role of the PAC1 receptor in neutrophil recruitment, acute-phase response, and nitric oxide production in septic shock J. Leukoc. Biol., May 1, 2005; 77(5): 729 - 738. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kato, A. Ito, J. Kawanokuchi, S. Jin, T. Mizuno, K. Ojika, R. Ueda, and A. Suzumura Pituitary adenylate cyclase-activating polypeptide (PACAP) ameliorates experimental autoimmune encephalomyelitis by suppressing the functions of antigen presenting cells Multiple Sclerosis, December 1, 2004; 10(6): 651 - 659. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Steinhoff, S. Stander, S. Seeliger, J. C. Ansel, M. Schmelz, and T. Luger Modern Aspects of Cutaneous Neurogenic Inflammation Arch Dermatol, November 1, 2003; 139(11): 1479 - 1488. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. DELGADO, C. ABAD, C. MARTINEZ, M. G. JUARRANZ, J. LECETA, D. GANEA, and R. P. GOMARIZ PACAP in Immunity and Inflammation Ann. N.Y. Acad. Sci., May 1, 2003; 992(1): 141 - 157. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
